Establishment Labs Holdings Inc. (ESTA) Stock Price
ESTAStock
$59.18+27.02%52W
Market Cap$1.76B
P/E—
PEG Ratio—
Div yield—
Beta1.02
ESTA Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-20.89%
Price vs S&P 500 (4W)-11.31%
VGM Score48.21
ESTA Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.30 | -$0.32 | -4.16%(-$0.01) | |
| Q1 2026 | -$0.38 | -$0.40 | -4.61%(-$0.02) | |
| Q4 2025 | -$0.21 | -$0.09 | +58.14%(+$0.13) | |
| Q3 2025 | -$0.51 | -$0.38 | +25.97%(+$0.13) | |
| Q2 2025 | -$0.56 | -$0.56 | +1.75%(+$0.01) |
ESTA Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.20
4.20
4.20
4.33
Industry Peers — Orthopedic & Prosthetic Devices(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
ESTAEstablishment Labs Holdings Inc. | F | A | C | 7.2x | 20.0% | 70.5% | -7.6% | $59.18 |
| ISRGIntuitive Surgical Inc. | D | B | B | 13.7x | 18.2% | 66.7% | 31.3% | $426.70 |
| EWEdwards Lifesciences Corp | D | C | B | 7.7x | 6.7% | 77.8% | 18.2% | $86.60 |
| STESTERIS plc | C | C | B | 3.6x | 13.8% | 44.4% | 18.9% | $222.66 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | B | 2.1x | 3.2% | 69.9% | 14.2% | $94.98 |
| SNNSmith & Nephew plc | B | C | C | 1.9x | 6.2% | 68.2% | 12.9% | $29.06 |
| ALGNAlign Technology Inc | B | D | C | 2.5x | 10.3% | 69.0% | 13.2% | $147.31 |
| MSAMine Safety Incorporated | C | C | B | 3.5x | 6.8% | 47.6% | 21.2% | $179.05 |
| ENOVEnovis Corporation | B | D | C | 0.5x | -6.0% | 61.4% | -45.1% | $19.59 |
| CDRECadre Holdings, Inc. | B | C | C | 1.6x | 8.6% | 41.8% | 10.1% | $26.38 |
| AVRAnteris Technologies Global Corp. Common Stock | D | C | C | 263.0x | — | 75.0% | -4738.4% | $6.05 |
About Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc. is a medical technology company specializing in the design, manufacture, and distribution of silicone-filled breast and body-shaping implants under the Motiva brand. The company distributes its aesthetic medical devices through direct sales channels to physicians, hospitals, clinics, and medical distributors across Europe, Latin America, Asia-Pacific, the Middle East, and other regions.